2024-10-19 14:28:17
Immorna Announces First Subject Dosed in a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Vaccine Developed for the Prevention of Shingles
Health/ 2023-07-22
Immorna Announces First Subject Dosed in...

MORRISVILLE,N.C.,May 30,2023-- Immorna,a rapidly expanding biotechnology company focusing on the development of multi-platform RNA-based the...

Boryung Partners with Axiom Space and Aurelia Institute to Launch the "2023 Humans In Space" Program
Corporate/ 2023-07-24
Boryung Partners with Axiom Space and Au...

"Humans In Space" program co-hosted by Boryung,Axiom Space and Aurelia Institute to explore three interdisciplinary pillars of hea...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release